Table 3. Outcomes of patients co-colonized with VRE and MRSA*.
| Outcome | MRSA/VRE co-colonization, n = 65 | No co-colonization, n = 2,375 | p value |
|---|---|---|---|
| Death, n (%) | 16 (24.6) | 420 (17.7) | 0.15 |
| Mean length (d) of hospital stay (SD) | 12.0 (16.5) | 14.0 (17.8) | 0.37 |
| Subsequent MRSA-positive clinical culture, n (%) | 2 (3.1) | 34 (1.4) | <0.01 |
| Subsequent VRE-positive clinical culture, n (%) | 2 (3.1) | 39 (1.6) | 0.38 |
| Discharge location | |||
| Home or self-care, n (%) | 27 (41.5) | 1,467 (61.8) | <0.01 |
| Hospital, n (%) | 21 (32.3) | 368 (15.5) | <0.01 |
| Rehabilitation facility, n (%) | 1 (1.5) | 62 (2.6) | 0.59 |
| Unknown, n (%) | 0 | 18 (0.8) | 0.48 |
*VRE, vancomycin-resistant enterococci; MRSA, methicillin-resistant Staphylococcus aureus; SD, standard deviation.